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N-Terminal Truncated Cardiac TnI Extends Frank-Starling Response of
the Heart
Hanzhong Feng, Xupei Huang, J.-P. Jin.
Cardiac TnI (cTnI) has an N-terminal extension containing two protein kinase
A (PKA) phosphorylation sites, Ser23/24, and its removal by restrictive prote-
olysis in cardiac adaptation improves myocardial relaxation. Through trans-
genic expression of the N-terminal truncated cTnI (cTnI-ND) in the heart of
endogenous cTnI knockout mice, we studied the function of cardiac muscle
containing only cTnI-ND. The pure cTnI-ND hearts showed no hypertrophy
or dilation with normal baseline function as compared to wild type controls
(WT), confirming the non-destructive nature of cTnI-ND. Echocardiography
found increased left ventricular end diastolic dimension in cTnI-ND hearts as
compared to WT, implying increased relaxation and compliance in vivo. A se-
ries of preloads was tested in ex vivo working hearts for the effects of cTnI-ND
on Frank-Starling response. cTnI-ND hearts showed responses to 5-10 mmHg
preloads similar to that of WT. When preload was increased from 10 to 20
mmHg, cTnI-ND hearts exhibited better maintained left ventricular relaxation
velocity, lower left ventricular end diastolic pressure and larger stroke volume
responses than that of WT hearts. 10 nM isoproterenol further increased the
positive effects of cTnI-ND on the responses of cardiac function to preloads,
indicating that cTnI-ND enhances Frank-Starling relationship in the absence
of direct effect of PKA phosphorylation at Ser23/24. Slack sarcomere length
in isolated cardiomyocytes and the optimal sarcomere length for maximum ten-
sion development in intact left ventricular papillary muscle from cTnI-NDmice
were similar to that of WT, suggesting that cTnI-ND extends the range of
Frank-Starling response to high preloads by enhancing contractility indepen-
dent of further increases in sarcomere length. The results demonstrated that
the removal of cTnI N-terminal extension by restrictive proteolysis provides
a novel posttranslational modification to utilize Frank-Starling mechanism in
cardiac adaptation to physiological and pathological stresses.
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Myopathic Splice-Out of the Exon 7 segment of Cardiac Troponin T
Predominantly Impairs Systolic Function of the Heart
Hanzhong Feng, Guozhen Chen, Changlong Nan, J.-P. Jin.
The abnormal splice-out of the exon 7-encoded segment in the N-terminal vari-
able region of cardiac troponin T (cTnT-DE7) found in turkeys and dogswith di-
lated cardiomyopathy significantly reduced the function of transgenic mouse
hearts over-expressing cTnT-DE7 (Wei et al., JBC, 2010). Significantly de-
creased left ventricular peak pressure and contractile and relaxation velocities
with elongated isovolumic contraction and relaxation time were seen in ex
vivo working hearts from cTnT-DE7 mice in the absence of beta-adrenergic
tone, which were correctable by physiological levels of isoproterenol. To further
investigate the pathogenic mechanism of cTnT-DE7 under systemic neurohu-
moral regulation, echocardiography was employed to measure the function of
cTnT-DE7 transgenic mouse hearts in vivo. No atrial enlargement, ventricular
hypertrophy or dilation was detected in the hearts of 3 months old cTnT-DE7
mice, indicating a compensated state. However, left ventricular fractional short-
ening and ejection fractionwere significantly decreased in cTnT-DE7mice com-
pared to wild type controls. Under both baseline and beta-adrenergic stimulated
conditions, the left ventricular outflow tract velocity and gradient were both sig-
nificantly decreased in the transgenicmouse hearts, indicating decreased systolic
function. The impaired systolic heart function in vivo without changes in dia-
stolic function suggests that cTnT-DE7 primarily reduces contractile function
of the cardiacmuscle. Interestingly, a restrictive proteolytic deletion of theN-ter-
minal variable region of cTnT (Feng et al., J. Physiol. 2008) was increased in the
cTnT-DE7 hearts in vivo. This adaptive response may compensate for the de-
creased systolic function from the N-terminal abnormality of cTnT-DE7. Our
study demonstrated that the N-terminal variable region of cTnT is a regulatory
element for cardiac systolic function and a therapeutic target in heart failure.
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Pathophysiologic Changes Induced by Mutations in the TNT1 Domain of
cTnT that Cause FHC
Lauren Tal, Rachel K. Moore, Candice Dowell-Martino, Jil C. Tardiff.
Familial Hypertrophic Cardiomyopathy (FHC) is a primary cardiac muscle dis-
order and one of the most common causes of sudden cardiac death in young peo-
ple. Amajority of Cardiac Troponin T (cTnT)mutations are located in the TNT1
domain and cluster at its N- and C-termini. We are investigating the cTnT dele-
tion of glutamine 160 (delta-160E) that is known to be a severe mutation located
in a predicted hinge region at the C-terminal end of TNT1. Previous in vitromo-
tility studies in our laboratory showed that mutations in this region disrupt weak
electrostatic interactions between the thin filament and myosin necessary for
strong crossbridge formation. In the current study, we aim to examine the down-stream pathophysioloic consequences of this mutation. Cardiac myocytes iso-
lated from hearts of transgenic mice expressing delta-160E cTnT with 35%
and 70% replacement and non-transgenic siblings were used to study mechani-
cal function and calcium transients. Our study shows impairments in myocellu-
lar mechanics during contraction and relaxation and in the rise and decline of the
calcium transient. Furthermore, the alterations in calcium kinetics were dose-
dependent. These results support the progressive nature of delta-160E FHC sug-
gested by electron micrographs that demonstrate ultrastructural sarcomeric dis-
array that increase with transgene expression. In addition, we determined
downstream effects of the mutation on expression and function of calcium han-
dling proteins in transgenic mouse hearts using functional assays and immuno-
blotting. We found that the delta-160E cTnT mutation causes secondary
alterations in calcium handling, leading to decreased SR calcium uptake, in-
creased NCX expression, and increased diastolic leak through RyR2. Collec-
tively, these novel findings indicate a phenotype that is distinct from other
cTnT mutations and support the need to establish genotype-phenotype links in
order to better design molecular therapies to treat FHC.
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N-Terminal Truncated Cardiac TnI Improves Cardiac Function In Vivo
and Rescues Restrictive Cardiomyopathy
Pierre-Yves Jean-Charles, Yuejin Li, Changlong Nan, Guozheng Chen,
Han-Zhong Feng, J-P Jin, Xupei Huang.
Our previous studies have demonstrated that the phenotype of the transgenic
mouse hearts expressing a restrictive cardiomyopathy (RCM) cardiac troponin
I (cTnI) C-terminalmutation (R193H) is characterized by a diastolic dysfunction
and sudden cardiac death (SCD) (Du et al, 2006, 2008). We have also observed
that restrictive cleavage of the N-terminal extension of cTnI (cTnI-ND) that oc-
curs in physiological and pathological adaptations (Yu et al., 2001; Feng et al,
2008;McConnell et al., 2009) desensitizesmyofibril sensitivity for Ca2þ and en-
hances diastolic function in transgenicmice expressing cTnI-ND (Li et al, 2010).
In the present study, we generated double transgenicmice (Double-TG) express-
ing different levels of mutant cTnI R193H and cTnI-ND to investigate the dose-
dependent rescue effect of cTnI-ND and the mechanisms underlying the protec-
tive role of cTnI-ND in young and aged RCMmice. In 2-month-old Double-TG
mice, cTnI-ND rescuesRCMmice by correcting diastolic dysfunction caused by
cTnI R193H mutation in the heart. The rescue effect of cTnI-ND shows a dose-
dependent manner. In 8-10-month-old Double-TG mice, echocardiography and
Doppler data indicate that cTnI-ND rescues RCMmice not only by reversing the
diastolic dysfunction, but also by improving systolic function in the heart, since
both diastolic and systolic functions are deteriorated in aged RCM mice. Cell-
based assays measuring cardiac cell contractility further confirm the dose-
dependent protective effect of cTnI-ND in correcting the impaired relaxation
in isolated cardiac myocytes from various Double-TG mouse lines. Consistent
with the beneficial effect of cTnI-ND on the function of non-myopathic aging
hearts (Biesiadescki et al., 2010), these data demonstrate that cTnI-ND can res-
cue RCMphenotype not only by correcting diastolic dysfunction in youngRCM
mice but also by improving systolic function in aged RCM mice.
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Dose-Dependent Arrhythmia and Cardiac Dysfunction in Restrictive
Cardiomyopathy Mice Due to Troponin Mutations
Yuejin Li, Pierre-Yves Jean-Charles, Changlong Nan, Guozhen Chen,
Xupei Huang.
Restrictive cardiomyopathy (RCM) is associated with a cardiac troponin I
(cTnI) C-terminal mutation (R192H) in human patients. The transgenic mice
expressing this mutation have confirmed a phenotype of a diastolic dysfunction
and sudden cardiac death (SCD) (Du et al, 2006, 2008). In the present study, we
generated transgenic mice (cTnI193His) expressing different levels of mutant
cTnI R193H (mouse cTnI sequence) to investigate the dose-dependent cardiac
dysfunction and to reveal the cause of the death in RCM mice. Our results in-
dicated that the mice (cTnI193His/KO expressing only the mutant cTnI R193H at
a wild type cTnI-null background had a dramatic early death at one-month old
after birth. Telemetric ECG recording from these mice showed a significant
bradycardia starting on day 22 or 23 after birth and a significant ischemia
and arrhythmia 1-2 days before death. The diastolic function was deteriorated
in these mice determined by echocardiography compared to wild type and the
transgenic cTnI193His mice expressing 25% cTnI R193H and 75% wild type
cTnI. Cell-based experiments indicated that myocardial contractility decreased
significantly corresponding to the content of the mutant cTnI levels in cardiac
myocytes and the alteration of Ca2þ dynamics in the mutant cTnI cardiac my-
ocytes also showed a dose-dependent manner. Our study has demonstrated that
cTnI R193Hmutation-caused cardiac dysfunction is dose dependent. Bradycar-
dia is likely an adaptive mechanism of RCM mice to compensate for the pro-
longed relaxation. The main cause of the death in RCM mice is associated with
Tuesday, March 8, 2011 453afatal arrhythmia and ventricular ischemia due to the restricted ventricles and
enlarged atria. The transgenic mouse model provides us with a good tool to
study the mechanisms and the cause of the death of RCM, which will be useful
for the prevention and treatment of the disease.
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Both PKA Treatment and Cardiac Troponin-I N-Terminal Phosphoryla-
tion Alone Decrease Ca-Sensitivity and Eliminate Length-Dependent
Activation in Skinned Cardiac Muscle
Donald A. Martyn, Steven Korte, Maria Razumova, Erik Feest,
Thomas Irving, Michael Regnier.
Protein kinase A (PKA) phosphorylation of myofibrillar proteins constitutes an
important pathway forb-adrenergicmodulation of cardiac contractility. PKA tar-
gets the cardiac troponin I (cTnI) N-terminus, cardiac myosin-binding protein C
(cMyBP-C) and titin. To isolate cTnI and cMyBP-C /titin phosphorylation effects
on force-[Ca2þ] relations, endogenous cardiac troponin (Tn) was exchanged in
rat, skinned trabeculae with either WT Tn or Tn containing a non-
phosphorylatable mutant cTnI(S23/24A) or phosphomimetic cTnI(S23/24D).
PKA cannot phosphorylate either cTnI mutant, leaving cMyBP-C and titin as
sole PKA targets. Force-[Ca2þ] relations andCa2þ-sensitivity (pCa50)weremea-
sured at 2.3 and 2.0mmSL.Decreasing steady SL reducedmaximal force (Fmax)
and pCa50 similarly with WT Tn and Tn containing cTnI(S23/24A). PKA treat-
ment of native, WT and cTnI(S23/24A) exchanged trabeculae reduced pCa50 at
2.3, but not 2.0 umSL, eliminatingSL-dependence of pCa50.Reconstitutionwith
Tn containing cTnI(S23/24D) reduced pCa50 at both SL (compared to WT and
cTnI(S23,24A) and eliminated pCa50 SL-dependence; PKA did not significantly
alter pCa50 at either SL. At each SL Fmax was similar with WT and mutant tro-
ponins, and was unaffected by PKA. Low angle x-ray diffraction experiments
were performed to determine whether shifts in pCa50 were associated with
changes inmyofilament spacing (D1,0) or interaction.D1,0 at 2.3 umSLwas sim-
ilar in native trabeculae, withWT Tn and Tn containing either cTnI(S23,24A) or
cTnI(S23,24D); PKA increased D1,0 in all cases. The results suggest that PKA
phosphorylation of either cTnI or cMyBP-C /titin reduced the Ca2þ-sensitivity
of force and length-dependent activation. Supported by NIH HL067071-06.
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Reducing Thin Filament Ca2þ Affinity with a cTnC Variant (L57Q) Re-
duces Force but Enhances Cross-Bridge Dependence of Cooperative
Activation in Demembranated Rat Trabeculae
Cameron W. Turtle, Frederick S. Korte, Maria V. Razumova,
Michael Regnier.
Activation of cardiac contraction is initiated by binding of Ca2þ to troponin C
(cTnC) and regulated by cooperative strong cross-bridge binding. We previ-
ously showed that passive exchange with cTn containing a cTnC variant,
L48Q, increased Ca2þ sensitivity of force development and eliminated sarco-
mere length (SL) dependence of Ca2þ sensitivity of force in rat cardiac trabec-
ulae. This was shown to be due to decreased reliance on strong cross-bridge
binding for full thin-filament activation, possibly due to stronger cTnC-cTnI in-
teraction. We also showed that PKA phosphorylation decreased Ca2þ sensitiv-
ity of force and eliminated SL dependence of force-pCa relations, by unknown
specific mechanisms. Here we test the hypothesis that incorporation of a cTnC
variant with decreased Ca2þ binding affinity, L57Q cTnC, will result in in-
creased reliance on cross-bridge binding for full activation, thus increasing
SL-dependence of Ca2þ sensitivity. As expected, results indicate trabeculae
passively exchanged with L57Q cTnC-cTn displayed decreased Ca2þ sensitiv-
ity and rate of force production compared to WT cTnC at a given [Ca2þ]. In-
terestingly, preliminary results indicate L57Q cTnC-cTn mildly increased the
SL-dependence of Ca2þ sensitivity of force and also significantly decreased
maximal force. Both of these effects were not observed in PKA-treated trabec-
ulae, which had a comparable reduction in Ca2þ sensitivity of force. These
findings suggest that reducing cTnC Ca2þ affinity per se can reduce Ca2þ sen-
sitivity of contractile activation to the point of limited overall force production,
which may enhance cross-bridge dependence of cooperative thin filament acti-
vation. Current experiments aim to increase force in L57Q cTnC (to near WT
cTnC) by increasing cross-bridge attachment using 2’-deoxy-ATP, which has
previously been shown to increase force and Ca2þ sensitivity while maintain-
ing SL dependence. NIH-HL65497(MR), AHA-2310117(FSK).
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Fluorescence Measurements Using Rhodamine-Labeled cTnCMutants In-
dicate Little Cooperative Interaction Between Cardiac Thin Filament
Regulatory Units
Don Martyn, Vijay Rao, Michael Regnier.
Exchange of mixtures of WT cTnC and mutant cTnC(D65A), which cannot
bind Ca2þ at N-terminal site II (‘‘dead’’ cTnC), reduced maximal Ca2þ acti-
vated force (Fmax) with little effect on force-Ca2þ relations and force kineticsin skinned cardiac trabeculae (Gillis et al., J Physiol. 580:561-76, 2007), sug-
gesting interaction between structural regulatory units (RUs; 7 actins, 1 tropo-
nin, 1 tropomyosin) along cardiac thin filaments is less than in skeletal muscle
(Regnier et al., J Physiol. 540:485-97, 2002). To more directly test that this
finding, we exchanged skinned cardiac trabeculae with mixtures of mutant
cTnC(C35S) and cTnC(C35S,D65A), with one or the other labeled at Cys 84
with 5’tetramethyl rhodamine (IATR) for dichroism measurements. In trabec-
ulae exchanged with 100% cTnC(C35S)-IATR, dichroism increased in re-
sponse to both Ca2þ and rigor crossbridges, while trabeculae with 100% Tn
containing (cTnC(C35S,D65A)-IATR) had no response to Ca2þ, but retained
a strong response to rigor crossbridge binding. This response to strong cross-
bridges allows use of cTnC(C35S,D65A)-IATR to determine if isolated regu-
latory units containing cTnC(C35S,D65A)-IATR are perturbed by Ca2þ-
induced active contraction in adjacent ‘‘live’’ RUs. To test this, trabeculae
were exchanged with a mixture of 20% functional cTnC(C35S)-IATR and
80% unlabeled cTnC(C35S,D65A), to isolate functional RUs. Fmax decreased
but there was little change in the Ca2þ-dependence of dichroism compared to
trabeculae exchanged with 100% functional cTnC(C35S)-IATR. These data in-
dicate minimal or no apparent spread of activation between adjacent RUs in
cardiac muscle, indicating that the apparent cooperativity of force production
in cardiac muscle results from interactions between myosin and thin filaments
within a thin filament structural regulatory unit. Supported by NIH RO1-
HL65497 (Regnier).
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Combination of Phosphomimetic Substitutions within Cardiac Troponin I
Cause Functional Cross-Talk
Sarah E. Kampert, Tamara K. Stevenson, Mark A. Jensen, Erin M. Keyes,
Gail L. Romanchuk, Margaret V. Westfall.
Protein kinase C (PKC) phosphorylates 3 clusters of residues within cardiac tro-
ponin I (cTnI) andyet, it is unclearwhether phosphorylation atmultiple sites pro-
duces additive and/or divergent functional modifications. Our goal was to
evaluate the influence of cTnI with phosphomimetic substitutions on contractile
performance under basal conditions and in response to PKC activation by endo-
thelin. Endogenous cTnI was replaced with phosphomimetic substitutions using
adenoviral-mediated gene transfer into adult rat cardiac myocytes. Phosphomi-
metics of Ser43/45, Ser43/45 plus Thr144, and Ser23/24 plus Ser43/45 were
substituted with Asp to form AdcTnISer43/45Asp, cTnIAspTriple (e.g.
cTnISer43/45AspThrT144Asp), and cTnIAspQuad (cTnISer23/24/43/45Asp).
Isolatedmyocytes were electronically paced and studied 4 days after gene trans-
fer. Gene transfer of epitope-tagged versions of each construct resulted in 30-
40% replacement after 2 days and >65% replacement of endogenous cTnI 4
days after gene transfer without significant alterations in the expression of other
myofilament proteins. In functional studies, peak shortening amplitude was sig-
nificantly decreased in myocytes expressing cTnISer43/45Asp or cTnIAspQuad,
while peak shortening in myocytes expressing cTnIAspTriple was not signifi-
cantly different from controls. Relaxation was accelerated in myocytes express-
ing cTnIAspQuad, but was not different from controls in myocytes expressing
cTnIAspTriple or cTnISer43/45Asp. Together, these results suggest the Ser23/
24 and Ser43/45 sites have an additive influence on shortening, while substitu-
tion at Thr144 attenuates the influence of Ser43/45 on peak shortening. To fur-
ther determine whether multiple phosphomimetic substitutions within cTnI
influence myocyte shortening, we studied the change in peak shortening and re-
laxation produced by the PKC agonist, endothelin (10 nM). In preliminary stud-
ies, the increased peak amplitude and accelerated relaxation observed in control
myocytes is not significantly different in myocytes expressing cTnISer43/
45Asp. However, there is a trend for myocytes expressing cTnIAspQuad to
show an attenuated amplitude and relaxation response to ET.
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The Motif of Myosin Binding Protein-C is Mechanically Weak and
Extensible
Arpad Karsai, Samantha P. Harris, Miklo´s Kellermayer.
Cardiac myosin binding protein-C (cMyBP-C) is a member of the immuno-
globulin (Ig) superfamily of proteins and consists of 8 Ig- and 3 fibronectin
(Fn)-like domains along with a unique regulatory sequence referred to as the
MyBP-C ‘‘motif’’ or M-domain. The structure of the M-domain is not known,
but small angle X-ray scattering experiments suggest that it adopts a compact
shape in solution and that its overall dimensions are similar to other Ig-like do-
mains. To investigate whether the M-domain behaves similarly to an Ig domain
under mechanical stress or load, we used atomic force microscopy (AFM) to
investigate single molecule elasticity and mechanical properties of recombinant
full-length mouse cardiac cMyBP-C and smaller proteins containing just the M-
domain and flanking Ig- sequences. Force-extension curves of full-length
cMyBP-C showed unfolding of individual Ig or Fn-like domains at forces
